SEQ ID NO: 4

General Information


DRACP ID  DRACP01758

Peptide Name   SEQ ID NO: 4

Sequence  WRYMVm

Sequence Length  6

UniProt ID  Not available

PubChem CID  Not available

Origin  Not available

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
CT26 Mouse colon adenocarcinoma Carcinoma 2 μg/mouse of WRYMVm successfully inhibited tumor mass growth (50% against PBS control) on day 22. Tumor growth assay Not available Patent
EL4 Mouse precursor T cell lymphoblastic lymphoma/leukemia Lymphoma As shown in FIGS. 10A and 10B, WRYMVm was able to suppress tumor mass of EL4 Tumor growth assay Not available Patent

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antitumor



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  m=D-Methionine

Chiral  Mix



Physicochemical Information


Formula  C36H49N9O6S

Absent amino acids  ACDEFGHIKLNPQST

Common amino acids  MRVWY

Mass  82526

Pl  9.35

Basic residues  1

Acidic residues  0

Hydrophobic residues  2

Net charge  1

Boman Index  -634

Hydrophobicity  -10

Aliphatic Index  48.33

Half Life 
  /

Extinction Coefficient cystines  6990

Absorbance 280nm  1398

Polar residues  1

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID US2009/0118197A1

Patent Title  Immune-Modulating Peptide

Other Iinformation  Patent Application; Family: 15s / 15ex; Family Jurisdictions: KR, US, EP, CA, CN, JP, WO; Legal Status: Active; Application No: 24622908; Filed: Oct 6, 2008; Published: May 7, 2009; Earliest Priority: Jan 29, 2002; Granted: Sep 13, 2011

Other Published ID  CA2634902A1  CA2634902C  CN101370510A  CN101370510B  EP1976545A1  EP1976545B1  JP2009520812A  JP4880700B2  KR101040299B1  KR20080071194A  US2007219139A1  US7517857B2  US8017572B2  WO2007073127A1 




DRACP is developed by Dr.Zheng's team.